T&R Biofab Co. Ltd (246710.KQ) stock: key figures, P/E, revenue and dividend
Energy · Coal & Consumable Fuels · South Korea · ISIN KR7246710008
Price
1,835.00 KRW
Market cap
87.28 bn KRW
P/E (2025)
–
P/S (2025)
3.24
Dividend yield
0.00 %
Net margin
-118.48 %
Return on equity (ROE)
-122.55 %
Return on assets (ROA)
-34.46 %
T&R Biofab Co. Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 4.87 bn KRW | 26.97 bn KRW |
| Gross profit | 2.13 bn KRW | 6.88 bn KRW |
| Operating income | -8.77 bn KRW | -8.57 bn KRW |
| EBIT | -4.61 bn KRW | -25.87 bn KRW |
| Net income | -7.68 bn KRW | -31.95 bn KRW |
| Diluted EPS – continuing operations | -356.38 KRW | -671.74 KRW |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About T&R Biofab Co. Ltd
T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea.
More stocks
- Sambo Motors Co. Ltd (053700.KQ)
- HeXun Biosciences Co., Ltd. (6986.TWO)
- Morefield Group N.V. (MORE.AS)
- JUPITER NEUROSCIENCES, INC. (JUNS)
- Strong H Machinery Technology (Cayman) Incorporation (4560.TW)
- Gseven Co Ltd (2937.TWO)
- CHAMPIONS ONCOLOGY, INC. (CSBR)
- COGNITION THERAPEUTICS INC (CGTX)
- Integrated Solutions Technology, Inc. (6927.TWO)
- Pluk Phak Praw Rak Mae Public Company Limited (OKJ.BK)
- Datavan International (3521.TWO)
- SOLESENCE, INC. (SLSN)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.